Related Experiment Video
Updated: Jul 17, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
An intelligent data mining model approach for adverse effects of hormone replacement therapy
1School of Computing and Engineering, University of Missouri - Kansas City, Kansas City, MO, USA.
Methods of Information in Medicine
|January 17, 2007
Summary
This study found no significant link between hormone replacement therapy (HRT) and breast cancer onset. However, certain patient factors may increase breast cancer risk, guiding future research on medication efficacy and side effects.
Area of Science:
- Oncology
- Data Science
- Epidemiology
Background:
- Conflicting study results exist regarding hormone replacement therapy (HRT) and breast cancer risk.
- Previous research has yielded inconsistent findings on the association between HRT and breast cancer onset.
Purpose of the Study:
- To clarify contradictory outcomes on HRT and breast cancer by developing an intelligent data mining (IDM) model.
- To identify prognostic factors for cancer onset and provide alternative interpretations of clinical data.
Main Methods:
- A systematic review and meta-analysis of 22 randomized and case-control studies from the past 15 years concerning HRT and breast cancer.
- Utilized an IDM model, integrating data mining algorithms and public tools, to analyze the relationship and identify prognostic factors.
Main Results:
- No significant relationship was found between breast cancer onset and HRT in the overall pooled data analysis.
- Identified variables associated with cancer onset include age (60-69, 40-49), age at menopause (40-49), parity (0), and oophorectomy type.
- Suggests that HRT patients with specific physiological/pathological conditions and higher-ranked prognostic factors may have an increased breast cancer risk.
Conclusions:
- The IDM model can guide biomedical research in establishing causal relationships between medications and complications.
- Enables accurate assessment of new therapeutic treatments' efficacy and side effects in clinical trials.
- Reduces the reliance on large control populations for evaluating new treatments.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...